272 related articles for article (PubMed ID: 32404272)
1. The Role of Imaging in Health Screening: Screening for Specific Conditions.
Ballard DH; Burton KR; Lakomkin N; Kim S; Rajiah P; Patel MJ; Mazaheri P; Whitman GJ
Acad Radiol; 2021 Apr; 28(4):548-563. PubMed ID: 32404272
[TBL] [Abstract][Full Text] [Related]
2. The Role of Imaging in Health Screening: Overview, Rationale of Screening, and Screening Economics.
Ballard DH; Burton KR; Lakomkin N; Kim S; Rajiah P; Patel MJ; Mazaheri P; Whitman GJ
Acad Radiol; 2021 Apr; 28(4):540-547. PubMed ID: 32409140
[TBL] [Abstract][Full Text] [Related]
3. Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies.
Taylor SA; Mallett S; Miles A; Morris S; Quinn L; Clarke CS; Beare S; Bridgewater J; Goh V; Janes S; Koh DM; Morton A; Navani N; Oliver A; Padhani A; Punwani S; Rockall A; Halligan S
Health Technol Assess; 2019 Dec; 23(66):1-270. PubMed ID: 31855148
[TBL] [Abstract][Full Text] [Related]
4. [Preventive whole-body screening encompassing modern imaging using magnetic resonance tomography].
Baumgart D; Egelhof T
Herz; 2007 Aug; 32(5):387-94. PubMed ID: 17687528
[TBL] [Abstract][Full Text] [Related]
5. Whole-body magnetic resonance imaging (WB-MRI) for cancer screening in asymptomatic subjects of the general population: review and recommendations.
Zugni F; Padhani AR; Koh DM; Summers PE; Bellomi M; Petralia G
Cancer Imaging; 2020 May; 20(1):34. PubMed ID: 32393345
[TBL] [Abstract][Full Text] [Related]
6. Research Highlight: Artificial Intelligence for Ruling Out Negative Examinations in Screening Breast MRI.
Youk JH; Kim EK
Korean J Radiol; 2022 Feb; 23(2):153-155. PubMed ID: 35083890
[No Abstract] [Full Text] [Related]
7. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
[TBL] [Abstract][Full Text] [Related]
8. Imaging of liver tumours: What's new?
Vilgrain V; Raynaud L; Paulatto L; Ronot M
Liver Int; 2020 Feb; 40 Suppl 1():154-159. PubMed ID: 32077596
[TBL] [Abstract][Full Text] [Related]
9. Assessing the appropriateness of outpatient abdominopelvic CT and MRI examinations using the American College of Radiology Appropriateness Criteria.
Rosenkrantz AB; Marie K; Doshi A
Acad Radiol; 2015 Feb; 22(2):158-63. PubMed ID: 25442803
[TBL] [Abstract][Full Text] [Related]
10. Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience.
Walker R; Kessar P; Blanchard R; Dimasi M; Harper K; DeCarvalho V; Yucel EK; Patriquin L; Eustace S
J Magn Reson Imaging; 2000 Apr; 11(4):343-50. PubMed ID: 10767062
[TBL] [Abstract][Full Text] [Related]
11. Whole-Body Magnetic Resonance Imaging in Oncology: Uses and Indications.
Petralia G; Padhani AR
Magn Reson Imaging Clin N Am; 2018 Nov; 26(4):495-507. PubMed ID: 30316463
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography: a preliminary report.
Terauchi T; Murano T; Daisaki H; Kanou D; Shoda H; Kakinuma R; Hamashima C; Moriyama N; Kakizoe T
Ann Nucl Med; 2008 Jun; 22(5):379-85. PubMed ID: 18600415
[TBL] [Abstract][Full Text] [Related]
13. Perspectives for preventive screening with total body MRI.
Ladd SC; Ladd ME
Eur Radiol; 2007 Nov; 17(11):2889-97. PubMed ID: 17549492
[TBL] [Abstract][Full Text] [Related]
14. Artificial intelligence in assessment of hepatocellular carcinoma treatment response.
Spieler B; Sabottke C; Moawad AW; Gabr AM; Bashir MR; Do RKG; Yaghmai V; Rozenberg R; Gerena M; Yacoub J; Elsayes KM
Abdom Radiol (NY); 2021 Aug; 46(8):3660-3671. PubMed ID: 33786653
[TBL] [Abstract][Full Text] [Related]
15. ACR Appropriateness Criteria
; Horowitz JM; Kamel IR; Arif-Tiwari H; Asrani SK; Hindman NM; Kaur H; McNamara MM; Noto RB; Qayyum A; Lalani T
J Am Coll Radiol; 2017 May; 14(5S):S103-S117. PubMed ID: 28473066
[TBL] [Abstract][Full Text] [Related]
16. New Approaches and Recommendations for Risk-Adapted Breast Cancer Screening.
Tsarouchi MI; Hoxhaj A; Mann RM
J Magn Reson Imaging; 2023 Oct; 58(4):987-1010. PubMed ID: 37040474
[TBL] [Abstract][Full Text] [Related]
17. The lung cancers: staging and response, CT,
Owens C; Hindocha S; Lee R; Millard T; Sharma B
Br J Radiol; 2023 Aug; 96(1148):20220339. PubMed ID: 37097296
[TBL] [Abstract][Full Text] [Related]
18. Impact of whole-body CT screening on the cost-effectiveness of CT colonography.
Hassan C; Pickhardt PJ; Laghi A; Zullo A; Kim DH; Iafrate F; Di Giulio L; Morini S
Radiology; 2009 Apr; 251(1):156-65. PubMed ID: 19332851
[TBL] [Abstract][Full Text] [Related]
19. College of Radiology, Academy of Medicine of Malaysia position on whole body screening CT scans in healthy asymptomatic individuals (2008).
Ho E; Abdullah B; Tang A; Nordin A; Nair A; Lim G; Samad-Cheung H; Ng Kh; Ponnusamy S; Abbas S; Bux S; Arasaratnam S; Abdul Aziz Y; Venugopal S; Musa Z; Abdul Manaf Z
Biomed Imaging Interv J; 2008 Oct; 4(4):e44. PubMed ID: 21611021
[TBL] [Abstract][Full Text] [Related]
20. Whole-body magnetic resonance imaging in pediatric oncology - recommendations by the Oncology Task Force of the ESPR.
Schäfer JF; Granata C; von Kalle T; Kyncl M; Littooij AS; Di Paolo PL; Sefic Pasic I; Nievelstein RAJ;
Pediatr Radiol; 2020 Jul; 50(8):1162-1174. PubMed ID: 32468287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
